Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
TO UP 1001-1000 Annexin V FITC Reagent Biovision 1000 assays 945.5
ASK
Publication
TO UP 1001-1000 Annexin V FITC Reagent1000 assays Biovision 1000 assays 891
ASK
Publication
TO UP 1001-200 Annexin V FITC Reagent Biovision 200 assays 315.5
ASK
Publication
TO UP 1001-200 Annexin V FITC Reagent200 assays Biovision 200 assays 325
ASK
Publication
TO UP 1002-1000 Annexin V Cy3 Reagent Biovision 1000 assays 945.5
ASK
Publication
TO UP 1002-1000 Annexin V Cy3 Reagent1000 assays Biovision 1000 assays 891
ASK
Publication
TO UP 1002-200 Annexin V Cy3 Reagent Biovision 200 assays 315.5
ASK
Publication
TO UP 1002-200 Annexin V Cy3 Reagent200 assays Biovision 200 assays 325
ASK
Publication
TO UP 1003-100 Annexin V-Biotin Reagent Biovision 100 μg 318
ASK
Publication
TO UP 1003-100 Annexin V Biotin Reagent Biovision 100 ug 405.405
ASK
Publication
TO UP 1003-100 Annexin V Biotin Reagent100 ug (400 assays) Biovision 100 ug (400 assays) 306
ASK
Publication
TO UP 1003-1000 Annexin V Biotin Reagent Biovision 1 mg 1985
ASK
Publication
TO UP 1003-1000 Annexin V Biotin Reagent1 mg (4000 assays) Biovision 1 mg (4000 assays) 2073
ASK
Publication
TO UP 1004-1000 Annexin V EGFP Reagent Biovision 1000 assays 945.5
ASK
Publication
TO UP 1004-1000 Annexin V EGFP Reagent1000 assays Biovision 1000 assays 891
ASK
Publication
TO UP 1004-200 Annexin V EGFP Reagent Biovision 200 assays 315.5
ASK
Publication
TO UP 1004-200 Annexin V EGFP Reagent200 assays Biovision 200 assays 325
ASK
Publication
TO UP 1005-100 Annexin V Unlabeled Reagent100 ug Biovision 100 ug 230
ASK
Publication
TO UP 1005-100 Annexin V, human recombinant Biovision 100 ìg 250.425
ASK
Publication
TO UP 1005-1000 Annexin V Unlabeled Reagent1 mg Biovision 1 mg 1413
ASK
Publication
TO UP 1005-1000 Annexin V, human recombinant Biovision 1 mg 1445
ASK
Publication
TO UP 1005-5000 Annexin V Unlabeled Reagent5 mg Biovision 5 mg 4689
ASK
Publication
TO UP 1005-5000 Annexin V, human recombinant Biovision 5 mg 4545.5
ASK
Publication
TO UP 1006-100 10X Annexin V Binding Buffer Biovision 100 ml 144.5
ASK
Publication
TO UP 1006-100 10X Annexin V Binding Buffer100 ml Biovision 100 ml 145
ASK
Publication
TO UP 1006-100 Annexin V Binding Buffer, 10X Biovision 100 ml 152
ASK
Publication
TO UP 1007-1000 Caspase-3 Substrate DEVD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1007-1000 Caspase 3 Substrate DEVD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1007-1000 Caspase 3 Substrate DEVD AFC1000 assays Biovision 1000 assays 541
ASK
Publication
TO UP 1007-200 Caspase-3 Substrate DEVD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1007-200 Caspase 3 Substrate DEVD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1007-200 Caspase 3 Substrate DEVD AFC200 assays Biovision 200 assays 276
ASK
Publication
TO UP 1008-1000 Caspase-3 Substrate DEVD-pNA; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1008-1000 Caspase 3 Substrate DEVD pNA Biovision 1000 assays 613.305
ASK
Publication
TO UP 1008-1000 Caspase 3 Substrate DEVD pNA1000 assays Biovision 1000 assays 541
ASK
Publication
TO UP 1008-200 Caspase-3 Substrate DEVD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1008-200 Caspase 3 Substrate DEVD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1008-200 Caspase 3 Substrate DEVD pNA200 assays Biovision 200 assays 276
ASK
Publication
TO UP 1009-100 Caspase-3 Inhibitor Z-DEVD-FMK Biovision 100 167
ASK
Publication
TO UP 1009-100 Caspase-3 Inhibitor Z-DEVD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1009-100 Caspase 3 Inhibitor Z DEVD FMK Biovision 100 µl 165.375
ASK
Publication
TO UP 1009-100 Caspase 3 Inhibitor Z DEVD FMK 100 ul Biovision 100 ul 155
ASK
Publication
TO UP 1009-20C Caspase-3 Inhibitor Z-DEVD-FMK Biovision 20 167
ASK
Publication
TO UP 1009-20C Caspase-3 Inhibitor Z-DEVD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1009-20C Caspase 3 Inhibitor Z DEVD FMK Biovision 20 µl 165.375
ASK
Publication
TO UP 1009-20C Caspase 3 Inhibitor Z DEVD FMK 20 ul Biovision 20 ul 155.925
ASK
Publication
TO UP 1010-100 Caspase-Family Inhibitor Z-VAD-FMK Biovision 100 167
ASK
Publication
TO UP 1010-100 Caspase-Family Inhibitor Z-VAD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1010-100 Caspase Family Inhibitor Z VAD FMK Biovision 100 µl 165.375
ASK
Publication
TO UP 1010-100 Caspase Family Inhibitor Z VAD FMK 100 ul Biovision 100 ul 155.925
ASK
Publication
TO UP 1010-20C Caspase-Family Inhibitor Z-VAD-FMK Biovision 20 167
ASK
Publication
TO UP 1010-20C Caspase-Family Inhibitor Z-VAD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1010-20C Caspase Family Inhibitor Z VAD FMK Biovision 20 µl 165.375
ASK
Publication
TO UP 1010-20C Caspase Family Inhibitor Z VAD FMK 20 ul Biovision 20 ul 155.925
ASK
Publication
TO UP 1011-100 Caspase-6 Inhibitor Z-VEID-FMK Biovision 100 167
ASK
Publication
TO UP 1011-100 Caspase-6 Inhibitor Z-VEID-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1011-100 Caspase 6 Inhibitor Z VEID FMK Biovision 100 µl 165.375
ASK
Publication
TO UP 1011-100 Caspase 6 Inhibitor Z VEID FMK 100 ul Biovision 100 ul 155
ASK
Publication
TO UP 1011-20C Caspase-6 Inhibitor Z-VEID-FMK Biovision 20 167
ASK
Publication
TO UP 1011-20C Caspase-6 Inhibitor Z-VEID-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1011-20C Caspase 6 Inhibitor Z VEID FMK Biovision 20 µl 165.375
ASK
Publication
TO UP 1011-20C Caspase 6 Inhibitor Z VEID FMK 20 ul Biovision 20 ul 155
ASK
Publication
TO UP 1012-100 Caspase-1 Inhibitor Z-YVAD-FMK Biovision 100 167 Publication
TO UP 1012-100 Caspase-1 Inhibitor Z-YVAD-FMK ; Appearance Liquid Biovision 100 171.99 Publication
TO UP 1012-100 Caspase 1 Inhibitor Z YVAD FMK Biovision 100 µl 165 Publication
TO UP 1012-100 Caspase 1 Inhibitor Z YVAD FMK 100 ul Biovision 100 ul 155 Publication
TO UP 1012-20C Caspase-1 Inhibitor Z-YVAD-FMK Biovision 20 167
ASK
Publication
TO UP 1012-20C Caspase-1 Inhibitor Z-YVAD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1012-20C Caspase 1 Inhibitor Z YVAD FMK Biovision 20 µl 165.375
ASK
Publication
TO UP 1012-20C Caspase 1 Inhibitor Z YVAD FMK 20 ul Biovision 20 ul 155
ASK
Publication
TO UP 1013-1000 Annexin V Cy5 Reagent Biovision 1000 assays 945.5
ASK
Publication
TO UP 1013-1000 Annexin V Cy5 Reagent1000 assays Biovision 1000 assays 937
ASK
Publication
TO UP 1013-200 Annexin V Cy5 Reagent Biovision 200 assays 315.5
ASK
Publication
TO UP 1013-200 Annexin V Cy5 Reagent200 assays Biovision 200 assays 325.08
ASK
Publication
TO UP 1014-1000 Annexin V PE Reagent Biovision 1000 assays 945.5
ASK
Publication
TO UP 1014-1000 Annexin V PE Reagent1000 assays Biovision 1000 assays 937
ASK
Publication
TO UP 1014-200 Annexin V PE Reagent Biovision 200 assays 315.5
ASK
Publication
TO UP 1014-200 Annexin V PE Reagent200 assays Biovision 200 assays 325
ASK
Publication
TO UP 1015-1000 Annexin V PE Cy5 Reagent Biovision 1000 assays 945.5
ASK
Publication
TO UP 1015-1000 Annexin V PE Cy5 Reagent1000 assays Biovision 1000 assays 984
ASK
Publication
TO UP 1015-200 Annexin V PE Cy5 Reagent Biovision 200 assays 342.5
ASK
Publication
TO UP 1015-200 Annexin V PE Cy5 Reagent200 assays Biovision 200 assays 352
ASK
Publication
TO UP 1021-5 Cathepsin B (active, human) Biovision 5 ìg 165.375
ASK
Publication
TO UP 1021-5 Cathepsin B (active, human)5 ug Biovision 5 ug 145
ASK
Publication
TO UP 1022-5 Cathepsin D (active, human) Biovision 5 ìg 165.375
ASK
Publication
TO UP 1022-5 Cathepsin D (active, human)5 ug Biovision 5 ug 145
ASK
Publication
TO UP 1023-5 Cathepsin H (active, human) Biovision 5 ìg 165.375
ASK
Publication
TO UP 1023-5 Cathepsin H (active, human)5 ug Biovision 5 ug 145
ASK
Publication
TO UP 1025-5 Cathepsin S (active, human) Biovision 5 ìg 165.375
ASK
Publication
TO UP 1025-5 Cathepsin S (active, human)5 ug Biovision 5 ug 145
ASK
Publication
TO UP 1026-10 Procathepsin K, human recombinant Biovision 10 μg 286.934 Publication
TO UP 1035-100 1X Annexin V Binding Buffer Biovision 100 ml 149.31 Publication
TO UP 1035-100 1X Annexin V Binding Buffer100 ml Biovision 100 ml 118 Publication
TO UP 1035-100 Annexin V Binding Buffer, 1X Biovision 100 ml 123 Publication
TO UP 1036-50 Actinomycin D (10 mM) Biovision 50 µl 104.895
ASK
Publication
TO UP 1036-50 Actinomycin D (10 mM)50 ul Biovision 50 ul 99.225
ASK
Publication
TO UP 1036-50 Actinomycin D (10 mM); Appearance Liquid Biovision 50 115.29
ASK
Publication
TO UP 1036-50MG Actinomycin D Biovision 50 mg 435
ASK
Publication
TO UP 1036-50MG Actinomycin D 50 mg Biovision 50 mg 419.58
ASK
Publication
TO UP 1036-50MG Actinomycin D ; Appearance Red-Orange Solid Biovision 50 mg 458.325
ASK
Publication
TO UP 1036-5MG Actinomycin D Biovision 5 mg 133
ASK
Publication
TO UP 1036-5MG Actinomycin D 5 mg Biovision 5 mg 120.96
ASK
Publication
TO UP 1036-5MG Actinomycin D ; Appearance Red-Orange Solid Biovision 5 mg 136.08
ASK
Publication
TO UP 1039-1 Camptothecin (2 mM) Biovision 1 ml 113
ASK
Publication
TO UP 1039-1 Camptothecin (2 mM)1 ml Biovision 1 ml 99.225
ASK
Publication
TO UP 1039-1 Camptothecin (2 mM); Appearance Liquid Biovision 1 ml 115.29
ASK
Publication
TO UP 1039-500MG Camptothecin Biovision 500 mg 308
ASK
Publication
TO UP 1039-500MG Camptothecin 500 mg Biovision 500 mg 295.785
ASK
Publication
TO UP 1039-500MG Camptothecin ; Appearance Pale yellow solid Biovision 500 mg 323.19
ASK
Publication
TO UP 1039-50MG Camptothecin Biovision 50 mg 127
ASK
Publication
TO UP 1039-50MG Camptothecin 50 mg Biovision 50 mg 120.96
ASK
Publication
TO UP 1039-50MG Camptothecin ; Appearance Pale yellow solid Biovision 50 mg 129.465
ASK
Publication
TO UP 1041-1 Cycloheximide (100 mM) Biovision 1 ml 118
ASK
Publication
TO UP 1041-1 Cycloheximide (100 mM)1 ml Biovision 1 ml 107.73
ASK
Publication
TO UP 1041-1 Cycloheximide (100 mM); Appearance Liquid Biovision 1 ml 120.015
ASK
Publication
TO UP 1041-1G Cycloheximide Biovision 1 g 143
ASK
Publication
TO UP 1041-1G Cycloheximide 1 g Biovision 1 g 137.025
ASK
Publication
TO UP 1041-1G Cycloheximide ; Appearance Off-white solid Biovision 1 g 145.53
ASK
Publication
TO UP 1041-5G Cycloheximide Biovision 5 g 240
ASK
Publication
TO UP 1041-5G Cycloheximide ; Appearance Off-white solid Biovision 5 g 249.48
ASK
Publication
TO UP 1042-1 Dexamethasone (10 mM) Biovision 1 ml 113
ASK
Publication
TO UP 1042-1 Dexamethasone (10 mM)1 ml Biovision 1 ml 99.225
ASK
Publication
TO UP 1042-1 Dexamethasone (10 mM); Appearance Liquid Biovision 1 ml 115.29
ASK
Publication
TO UP 1042-10G Dexamethasone Biovision 10 g 533
ASK
Publication
TO UP 1042-10G Dexamethasone 10 g Biovision 10 g 514.08
ASK
Publication
TO UP 1042-10G Dexamethasone ; Appearance White solid Biovision 10 g 561.33
ASK
Publication
TO UP 1042-1G Dexamethasone Biovision 1 g 147
ASK
Publication
TO UP 1042-1G Dexamethasone 1 g Biovision 1 g 139.86
ASK
Publication
TO UP 1042-1G Dexamethasone ; Appearance White solid Biovision 1 g 150.255
ASK
Publication
TO UP 1043-100 Etoposide (10 mM)100 ul Biovision 100 ul 99.225
ASK
Publication
TO UP 1043-100 Etoposide (100 mM) Biovision 100 µl 104.895
ASK
Publication
TO UP 1043-100 Etoposide (100 mM); Appearance Liquid Biovision 100 115.29
ASK
Publication
TO UP 1043-250MG Etoposide Biovision 250 mg 435
ASK
Publication
TO UP 1043-250MG Etoposide 250 mg Biovision 250 mg 419.58
ASK
Publication
TO UP 1043-250MG Etoposide ; Appearance White solid Biovision 250 mg 458.325
ASK
Publication
TO UP 1043-25MG Etoposide Biovision 25 mg 127
ASK
Publication
TO UP 1043-25MG Etoposide 25 mg Biovision 25 mg 120.96
ASK
Publication
TO UP 1043-25MG Etoposide ; Appearance White solid Biovision 25 mg 129.465
ASK
Publication
TO UP 1048-01 Staurosporine Biovision 100 µg 126.63
ASK
Publication
TO UP 1048-01 Staurosporine; Appearance Pale yellow solid Biovision 100 136.08
ASK
Publication
TO UP 1048-010 Staurosporine100 ug[DISCONTINUED] Biovision 100 ug 120.96
ASK
Publication
TO UP 1048-1 Staurosporine Biovision 1 mg 342
ASK
Publication
TO UP 1048-1 Staurosporine1 mg Biovision 1 mg 325.08
ASK
Publication
TO UP 1048-1 Staurosporine; Appearance Pale yellow solid Biovision 1 mg 358.155
ASK
Publication
TO UP 1050-10 Human TNF alpha 10 ug Biovision 10 ug 118.125
ASK
Publication
TO UP 1050-10 TNF-alpha, human recombinant Biovision 10 μg 139.524
ASK
Publication
TO UP 1050-10 TNF alpha, human recombinant Biovision 10 ìg 127.575
ASK
Publication
TO UP 1050-1000 Human TNF alpha 1 mg Biovision 1 mg 1366.47
ASK
Publication
TO UP 1050-1000 TNF alpha, human recombinant Biovision 1 mg 1577.89
ASK
Publication
TO UP 1050-50 Human TNF alpha50 ug Biovision 50 ug 0
ASK
Publication
TO UP 1050-50 TNF-alpha, human recombinant Biovision 50 μg 252.126
ASK
Publication
TO UP 1050-50 TNF alpha, human recombinant Biovision 50 ug 296.73
ASK
Publication
TO UP 1051-10 Murine TNF alpha10 ug Biovision 10 ug 164.43
ASK
Publication
TO UP 1051-10 TNF-alpha, murine recombinant Biovision 10 μg 190.701
ASK
Publication
TO UP 1051-10 TNF alpha, murine recombinant Biovision 10 ìg 186.165
ASK
Publication
TO UP 1051-1000 Murine TNF alpha1 mg Biovision 1 mg 2827.44
ASK
Publication
TO UP 1051-1000 TNF alpha, murine recombinant Biovision 1 mg 2970.19
ASK
Publication
TO UP 1051-50 Murine TNF alpha50 ug Biovision 50 ug 325.08
ASK
Publication
TO UP 1051-50 TNF-alpha, murine recombinant Biovision 50 μg 385.224
ASK
Publication
TO UP 1051-50 TNF alpha, murine recombinant Biovision 50 ìg 389.34
ASK
Publication
TO UP 1052-10 Rat TNF alpha 10 ug Biovision 10 ug 164.43
ASK
Publication
TO UP 1052-10 TNF-alpha, rat recombinant Biovision 10 μg 190.701
ASK
Publication
TO UP 1052-10 TNF alpha, rat recombinant Biovision 10 ìg 186.165
ASK
Publication
TO UP 1052-1000 Rat TNF alpha 1 mg Biovision 1 mg 2827.44
ASK
Publication
TO UP 1052-1000 TNF alpha, rat recombinant Biovision 1 mg 2970.19
ASK
Publication
TO UP 1052-50 Rat TNF alpha 50 ug Biovision 50 ug 325.08
ASK
Publication
TO UP 1052-50 TNF-alpha, rat recombinant Biovision 50 μg 385.224
ASK
Publication
TO UP 1052-50 TNF alpha, rat recombinant Biovision 50 ug 430.92
ASK
Publication
TO UP 1056-1 Propidium Iodide Biovision 1 ml 113
ASK
Publication
TO UP 1056-1 Propidium Iodide 1 ml Biovision 1 ml 99.225
ASK
Publication
TO UP 1056-1 Propidium Iodide ; Appearance Liquid Biovision 1 ml 115.29
ASK
Publication
TO UP 1062-1000 Caspase-8 Substrate IETD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1062-1000 Caspase 8 Substrate IETD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1062-1000 Caspase 8 Substrate IETD AFC1000 assays Biovision 1000 assays 514.08
ASK
Publication
TO UP 1062-200 Caspase-8 Substrate IETD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1062-200 Caspase 8 Substrate IETD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1062-200 Caspase 8 Substrate IETD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1063-1000 Caspase-8 Substrate IETD-pNA; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1063-1000 Caspase 8 Substrate IETD pNA Biovision 1000 assays 613.305
ASK
Publication
TO UP 1063-1000 Caspase 8 Substrate IETD pNA1000 assays Biovision 1000 assays 514.08
ASK
Publication
TO UP 1063-200 Caspase-8 Substrate IETD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1063-200 Caspase 8 Substrate IETD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1063-200 Caspase 8 Substrate IETD pNA200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1064-100 Caspase-8 Inhibitor Z-IETD-FMK Biovision 100 167
ASK
Publication
TO UP 1064-100 Caspase-8 Inhibitor Z-IETD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1064-100 Caspase 8 Inhibitor Z IETD FMK Biovision 100 µl (2 mM) 165.375
ASK
Publication
TO UP 1064-100 Caspase 8 Inhibitor Z IETD FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1064-20C Caspase-8 Inhibitor Z-IETD-FMK Biovision 20 167
ASK
Publication
TO UP 1064-20C Caspase-8 Inhibitor Z-IETD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1064-20C Caspase 8 Inhibitor Z IETD FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1064-20C Caspase 8 Inhibitor Z IETD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1066-100 Dilution Buffer Biovision 100 ml 133
ASK
Publication
TO UP 1066-100 Dilution Buffer 100 ml Biovision 100 ml 126.63
ASK
Publication
TO UP 1066-500 Dilution Buffer Biovision 500 ml 240
ASK
Publication
TO UP 1066-500 Dilution Buffer 500 ml Biovision 500 ml 230.58
ASK
Publication
TO UP 1067-100 Cell Lysis Buffer Biovision 100 ml 133
ASK
Publication
TO UP 1067-100 Cell Lysis Buffer 100 ml Biovision 100 ml 126.63
ASK
Publication
TO UP 1067-400 Cell Lysis Buffer Biovision 400 ml 240
ASK
Publication
TO UP 1067-400 Cell Lysis Buffer 400 ml Biovision 400 ml 230.58
ASK
Publication
TO UP 1068-20 2X Reaction Buffer Biovision 20 ml 126.5
ASK
Publication
TO UP 1068-20 2X Reaction Buffer 20 ml Biovision 20 ml 126.63
ASK
Publication
TO UP 1068-20 Reaction Buffer, 2X Biovision 20 ml 133
ASK
Publication
TO UP 1068-80 2X Reaction Buffer Biovision 80 ml 225.5
ASK
Publication
TO UP 1068-80 2X Reaction Buffer 80 ml Biovision 80 ml 230.58
ASK
Publication
TO UP 1068-80 Reaction Buffer, 2X Biovision 80 ml 240
ASK
Publication
TO UP 1069-1000 Caspase-6 Substrate VEID-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1069-1000 Caspase 6 Substrate VEID AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1069-1000 Caspase 6 Substrate VEID AFC1000 assays Biovision 1000 assays 514.08
ASK
Publication
TO UP 1069-200 Caspase-6 Substrate VEID-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1069-200 Caspase 6 Substrate VEID AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1069-200 Caspase 6 Substrate VEID AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1070-1000 Caspase-6 Substrate VEID-pNA; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1070-1000 Caspase 6 Substrate VEID pNA Biovision 1000 assays 613.305
ASK
Publication
TO UP 1070-1000 Caspase 6 Substrate VEID pNA1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1070-200 Caspase-6 Substrate VEID-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1070-200 Caspase 6 Substrate VEID pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1070-200 Caspase 6 Substrate VEID pNA200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1071-1000 Caspase-2 Substrate VDVAD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1071-1000 Caspase 2 Substrate VDVAD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1071-1000 Caspase 2 Substrate VDVAD AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1071-200 Caspase-2 Substrate VDVAD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1071-200 Caspase 2 Substrate VDVAD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1071-200 Caspase 2 Substrate VDVAD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1072-1000 Caspase-2 Substrate VDVAD-pNA; Appearance Liquid Biovision 1000 assays 635.04
ASK
Publication
TO UP 1072-1000 Caspase 2 Substrate VDVAD pNA Biovision 1000 assays 634.095
ASK
Publication
TO UP 1072-1000 Caspase 2 Substrate VDVAD pNA1000 assays Biovision 1000 assays 579.285
ASK
Publication
TO UP 1072-200 Caspase-2 Substrate VDVAD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1072-200 Caspase 2 Substrate VDVAD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1072-200 Caspase 2 Substrate VDVAD pNA200 assays Biovision 200 assays 287.28
ASK
Publication
TO UP 1073-100 Caspase-2 Inhibitor Z-VDVAD-FMK Biovision 100 167
ASK
Publication
TO UP 1073-100 Caspase-2 Inhibitor Z-VDVAD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1073-100 Caspase 2 Inhibitor Z VDVAD FMK Biovision 100 µl (2 mM) 165.375
ASK
Publication
TO UP 1073-100 Caspase 2 Inhibitor Z VDVAD FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1073-20C Caspase-2 Inhibitor Z-VDVAD-FMK Biovision 20 167
ASK
Publication
TO UP 1073-20C Caspase-2 Inhibitor Z-VDVAD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1073-20C Caspase 2 Inhibitor Z VDVAD FMK Biovision 20 µl(10 mM) 165.375
ASK
Publication
TO UP 1073-20C Caspase 2 Inhibitor Z VDVAD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1074-100 Caspase-9 Inhibitor Z-LEHD-FMK Biovision 100 167
ASK
Publication
TO UP 1074-100 Caspase-9 Inhibitor Z-LEHD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1074-100 Caspase 9 Inhibitor Z LEHD FMK Biovision 100 µl (2 mM) 165.375
ASK
Publication
TO UP 1074-100 Caspase 9 Inhibitor Z LEHD FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1074-20C Caspase-9 Inhibitor Z-LEHD-FMK Biovision 20 167
ASK
Publication
TO UP 1074-20C Caspase-9 Inhibitor Z-LEHD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1074-20C Caspase 9 Inhibitor Z LEHD FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1074-20C Caspase 9 Inhibitor Z LEHD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1075-1000 Caspase-9 Substrate LEHD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1075-1000 Caspase 9 Substrate LEHD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1075-1000 Caspase 9 Substrate LEHD AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1075-200 Caspase-9 Substrate LEHD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1075-200 Caspase 9 Substrate LEHD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1075-200 Caspase 9 Substrate LEHD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1076-1000 Caspase-9 Substrate LEHD-pNA; Appearance Liquid Biovision 1000 assays 635.04
ASK
Publication
TO UP 1076-1000 Caspase 9 Substrate LEHD pNA Biovision 1000 assays 634.095
ASK
Publication
TO UP 1076-1000 Caspase 9 Substrate LEHD pNA1000 assays Biovision 1000 assays 579.285
ASK
Publication
TO UP 1076-200 Caspase-9 Substrate LEHD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1076-200 Caspase 9 Substrate LEHD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1076-200 Caspase 9 Substrate LEHD pNA200 assays Biovision 200 assays 287.28
ASK
Publication
TO UP 1077-100 AFC (7-amino-4-trifluoromethyl-coumarin); Appearance Yellow powder Biovision 100 mg 115.29
ASK
Publication
TO UP 1077-100 AFC (7 amino 4 trifluoromethyl coumarin) Biovision 100 mg 114.345
ASK
Publication
TO UP 1077-100 AFC (7 amino 4 trifluoromethyl coumarin)100 mg Biovision 100 mg 107.73
ASK
Publication
TO UP 1078-100 pNA (p-nitroaniline); Appearance Golden yellow powder Biovision 100 mg 115.29
ASK
Publication
TO UP 1078-100 pNA (p nitroaniline) Biovision 100 mg 114.345
ASK
Publication
TO UP 1078-100 pNA (p nitroaniline)100 mg Biovision 100 mg 107.73
ASK
Publication
TO UP 1079-100 Caspase-12 Inhibitor Z-ATAD-FMK Biovision 100 191
ASK
Publication
TO UP 1079-100 Caspase-12 Inhibitor Z-ATAD-FMK; Appearance Liquid Biovision 100 198.45
ASK
Publication
TO UP 1079-100 Caspase 12 Inhibitor 100 ul (2 mM) Biovision 100 ul (2 mM) 183.33
ASK
Publication
TO UP 1079-100 Caspase 12 Inhibitor Z ATAD FMK Biovision 100 µl (2 mM) 197.505
ASK
Publication
TO UP 1079-20C Caspase-12 Inhibitor Z-ATAD-FMK Biovision 20 191
ASK
Publication
TO UP 1079-20C Caspase-12 Inhibitor Z-ATAD-FMK; Appearance Liquid Biovision 20 198.45
ASK
Publication
TO UP 1079-20C Caspase 12 Inhibitor 20 ul (10 mM) Biovision 20 ul (10 mM) 183.33
ASK
Publication
TO UP 1079-20C Caspase 12 Inhibitor Z ATAD FMK Biovision 20 µl (10 mM) 197.505
ASK
Publication
TO UP 1081-100 Active Human Caspase 1100 units Biovision 100 units 306.18
ASK
Publication
TO UP 1081-100 Caspase 1, human recombinant Biovision 100 units 315
ASK
Publication
TO UP 1081-25 Active Human Caspase 125 units Biovision 25 units 202.23
ASK
Publication
TO UP 1081-25 Caspase 1, human recombinant Biovision 25 units 231
ASK
Publication
TO UP 1082-100 Active Human Caspase 2100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1082-100 Caspase 2, human recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1082-25 Active Human Caspase 225 units Biovision 25 units 183.33
ASK
Publication
TO UP 1082-25 Caspase 2, human recombinant Biovision 25 units 198
ASK
Publication
TO UP 1083-10 Active Human Caspase 310 ug Biovision 10 ug 419.58
ASK
Publication
TO UP 1083-10 Caspase-3, human recombinant Biovision 10 μg 487.599
ASK
Publication
TO UP 1083-10 Caspase 3, human recombinant Biovision 10 ìg 463.995
ASK
Publication
TO UP 1083-100 Active Human Caspase 3100 units Biovision 100 units 230.58
ASK
Publication
TO UP 1083-100 Caspase 3, human recombinant Biovision 100 units 252
ASK
Publication
TO UP 1083-25 Active Human Caspase 325 units Biovision 25 units 126.63
ASK
Publication
TO UP 1083-25 Caspase 3, human recombinant Biovision 25 units 159.999
ASK
Publication
TO UP 1083-5 Active Human Caspase 35 ug Biovision 5 ug 257.985
ASK
Publication
TO UP 1083-5 Caspase-3, human recombinant Biovision 5 μg 303.324
ASK
Publication
TO UP 1083-5 Caspase 3, human recombinant Biovision 5 ìg 282.555
ASK
Publication
TO UP 1083P-5 Caspase-3 proform, human recombinant Biovision 5 μg 385.224
ASK
Publication
TO UP 1083P-5 Caspase 3 proform, human recombinant Biovision 5 ìg 357.21
ASK
Publication
TO UP 1083P-5 Human Procaspase 35 ug Biovision 5 ug 325.08
ASK
Publication
TO UP 1084-100 Active Human Caspase 41 unit Biovision 1 unit 295.785
ASK
Publication
TO UP 1084-100 Caspase-4, human recombinant Biovision 100 units 306
ASK
Publication
TO UP 1084-100 Caspase 4, human recombinant Biovision 1 unit 343.035
ASK
Publication
TO UP 1084-25 Active Human Caspase 41 unit Biovision 1 unit 183.33
ASK
Publication
TO UP 1084-25 Caspase-4, human recombinant Biovision 25 units 198
ASK
Publication
TO UP 1084-25 Caspase 4, human recombinant Biovision 1 unit 218.295
ASK
Publication
TO UP 1085-100 Active Human Caspase 5100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1085-100 Caspase 5, human recombinant Biovision 100 units 306
ASK
Publication
TO UP 1085-25 Active Human Caspase 525 units Biovision 25 units 183.33
ASK
Publication
TO UP 1085-25 Caspase 5, human recombinant Biovision 25 units 221.424
ASK
Publication
TO UP 1086-100 Active Human Caspase 6100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1086-100 Caspase 6, human recombinant Biovision 100 units 306
ASK
Publication
TO UP 1086-25 Active Human Caspase 625 units Biovision 25 units 183.33
ASK
Publication
TO UP 1086-25 Caspase 6, human recombinant Biovision 25 units 198
ASK
Publication
TO UP 1087-100 Active Human Caspase 7100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1087-100 Caspase 7, human recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1087-25 Active Human Caspase 725 units Biovision 25 units 183.33
ASK
Publication
TO UP 1087-25 Caspase 7, human recombinant Biovision 25units 198
ASK
Publication
TO UP 1088-100 Active Human Caspase 8100 units Biovision 100 units 295.785 Publication
TO UP 1088-100 Caspase 8, human recombinant Biovision 100 units 306 Publication
TO UP 1088-25 Active Human Caspase 825 units Biovision 25 units 183.33 Publication
TO UP 1088-25 Caspase 8, human recombinant Biovision 25 units 221.424 Publication
TO UP 1089-100 Caspase 9, human recombinant Biovision 100 units 315
ASK
Publication
TO UP 1089-25 Active Human Caspase 925 units Biovision 25 units 202.23
ASK
Publication
TO UP 1089-25 Caspase 9, human recombinant Biovision 25 units 231.651
ASK
Publication
TO UP 1089P-50 Caspase-9 Proform, human recombinant Biovision 50 μg 385.224
ASK
Publication
TO UP 1089P-50 Caspase-9 Proform, human recombinant Human Biovision 50 μg 342
ASK
Publication
TO UP 1089P-50 Caspase 9 Proform, human recombinant Biovision 50 ug 430.92
ASK
Publication
TO UP 1089P-50 Human Procaspase 950 ug Biovision 50 ug 325.08
ASK
Publication
TO UP 1090A-100 Active Human Caspase 10 a100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1090A-100 Caspase-10/a, human recombinant Biovision 100 units 343.035
ASK
Publication
TO UP 1090A-100 Caspase-10 a, human recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1090A-100 Caspase-10 a, human recombinant CASP10 Human Biovision 100 units 306
ASK
Publication
TO UP 1090A-100 Caspase 10 a, human recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1090A-25 Active Human Caspase 10 a25 units Biovision 25 units 183.33
ASK
Publication
TO UP 1090A-25 Caspase-10/a, human recombinant Biovision 25 units 218.295
ASK
Publication
TO UP 1090A-25 Caspase-10 a, human recombinant Biovision 25 units 221.424
ASK
Publication
TO UP 1090A-25 Caspase 10 a, human recombinant Biovision 25 units 221.424
ASK
Publication
TO UP 1090B-100 Active Human Caspase 10 b100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1090B-100 Caspase-10/b, human recombinant Biovision 100 units 343.035
ASK
Publication
TO UP 1090B-100 Caspase-10 b, human recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1090B-100 Caspase-10 b, human recombinant Human Biovision 100 units 306
ASK
Publication
TO UP 1090B-100 Caspase 10 b, human recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1090B-25 Active Human Caspase 10 b25 units Biovision 25 units 183.33
ASK
Publication
TO UP 1090B-25 Caspase-10/b, human recombinant Biovision 25 units 218.295
ASK
Publication
TO UP 1090B-25 Caspase-10 b, human recombinant Biovision 25 units 221.424
ASK
Publication
TO UP 1090B-25 Caspase 10 b, human recombinant Biovision 25 units 221.424
ASK
Publication
TO UP 1100-100 Caspase-5 Inhibitor Z-WEHD-FMK Biovision 100 167
ASK
Publication
TO UP 1100-100 Caspase-5 Inhibitor Z-WEHD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1100-100 Caspase 5 Inhibitor Z WEHD FMK Biovision 100 µl (2 mM) 165.375
ASK
Publication
TO UP 1100-100 Caspase 5 Inhibitor Z WEHD FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1100-20C Caspase-5 Inhibitor Z-WEHD-FMK Biovision 20 167
ASK
Publication
TO UP 1100-20C Caspase-5 Inhibitor Z-WEHD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1100-20C Caspase 5 Inhibitor Z WEHD FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1100-20C Caspase 5 Inhibitor Z WEHD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1101-1000 Caspase-5 Substrate WEHD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1101-1000 Caspase 5 Substrate WEHD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1101-1000 Caspase 5 Substrate WEHD AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1101-200 Caspase-5 Substrate WEHD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1101-200 Caspase 5 Substrate WEHD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1101-200 Caspase 5 Substrate WEHD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1102-1000 Caspase-5 Substrate WEHD-pNA; Appearance Liquid Biovision 1000 assays 635.04
ASK
Publication
TO UP 1102-1000 Caspase 5 Substrate WEHD pNA Biovision 1000 assays 634.095
ASK
Publication
TO UP 1102-1000 Caspase 5 Substrate WEHD pNA1000 assays Biovision 1000 assays 579.285
ASK
Publication
TO UP 1102-200 Caspase-5 Substrate WEHD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1102-200 Caspase 5 Substrate WEHD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1102-200 Caspase 5 Substrate WEHD pNA200 assays Biovision 200 assays 287.28
ASK
Publication
TO UP 1103-1000 Caspase-1 Substrate YVAD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1103-1000 Caspase 1 Substrate YVAD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1103-1000 Caspase 1 Substrate YVAD AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1103-200 Caspase-1 Substrate YVAD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1103-200 Caspase 1 Substrate YVAD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1103-200 Caspase 1 Substrate YVAD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1104-1000 Caspase-1 Substrate YVAD-pNA; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1104-1000 Caspase 1 Substrate YVAD pNA Biovision 1000 assays 613.305
ASK
Publication
TO UP 1104-1000 Caspase 1 Substrate YVAD pNA1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1104-200 Caspase-1 Substrate YVAD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1104-200 Caspase 1 Substrate YVAD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1104-200 Caspase 1 Substrate YVAD pNA200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1106-1000 Jurkat Cell Extract (Uninduced) Biovision 1 mg 269
ASK
Publication
TO UP 1106-1000 Jurkat Cell Extract (Uninduced)1 mg Biovision 1 mg 257.985
ASK
Publication
TO UP 1106-400 Jurkat Cell Extract (Uninduced) Biovision 400 ug 187.11
ASK
Publication
TO UP 1106-400 Jurkat Cell Extract (Uninduced)400 ug Biovision 400 ug 145.53
ASK
Publication
TO UP 1107-1000 Jurkat Cell Extract (Induced) Biovision 1 mg 269
ASK
Publication
TO UP 1107-1000 Jurkat Cell Extract (Induced)1 mg Biovision 1 mg 257.985
ASK
Publication
TO UP 1107-400 Jurkat Cell Extract (Induced) Biovision 400 ug 187.11
ASK
Publication
TO UP 1107-400 Jurkat Cell Extract (Induced)400 ug Biovision 400 ug 145.53
ASK
Publication
TO UP 1108-100 Caspase-4 Inhibitor Z-LEVD-FMK Biovision 100 167
ASK
Publication
TO UP 1108-100 Caspase-4 Inhibitor Z-LEVD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1108-100 Caspase 4 Inhibitor Z LEVD FMK Biovision 100 µl (2 mM) 165.375
ASK
Publication
TO UP 1108-100 Caspase 4 Inhibitor Z LEVD FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1108-20C Caspase-4 Inhibitor Z-LEVD-FMK Biovision 20 167
ASK
Publication
TO UP 1108-20C Caspase-4 Inhibitor Z-LEVD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1108-20C Caspase 4 Inhibitor Z LEVD FMK Biovision 20 µl(10 mM) 165.375
ASK
Publication
TO UP 1108-20C Caspase 4 Inhibitor Z LEVD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1109-1000 Caspase-4 Substrate LEVD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1109-1000 Caspase 4 Substrate LEVD AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1109-1000 Caspase 4 Substrate LEVD AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1109-200 Caspase-4 Substrate LEVD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1109-200 Caspase 4 Substrate LEVD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1109-200 Caspase 4 Substrate LEVD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1110-1000 Caspase-4 Substrate LEVD-pNA; Appearance Liquid Biovision 1000 assays 635.04
ASK
Publication
TO UP 1110-1000 Caspase 4 Substrate LEVD pNA Biovision 1000 assays 634.095
ASK
Publication
TO UP 1110-1000 Caspase 4 Substrate LEVD pNA1000 assays Biovision 1000 assays 579.285
ASK
Publication
TO UP 1110-200 Caspase-4 Substrate LEVD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1110-200 Caspase 4 Substrate LEVD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1110-200 Caspase 4 Substrate LEVD pNA200 assays Biovision 200 assays 287.28
ASK
Publication
TO UP 1112-100 Caspase-10 Inhibitor AEVD-FMK Biovision 100 167
ASK
Publication
TO UP 1112-100 Caspase-10 Inhibitor AEVD-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1112-100 Caspase 10 Inhibitor AEVD FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1112-20C Caspase-10 Inhibitor AEVD-FMK Biovision 20 167
ASK
Publication
TO UP 1112-20C Caspase-10 Inhibitor AEVD-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1112-20C Caspase 10 Inhibitor AEVD FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1112-20C Caspase 10 Inhibitor AEVD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1113-1000 Caspase-10 Substrate AEVD-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1113-1000 Caspase 10 Substrate AEVD AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1113-200 Caspase-10 Substrate AEVD-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1113-200 Caspase 10 Substrate AEVD AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1113-200 Caspase 10 Substrate AEVD AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1114-1000 Caspase-10 Substrate AEVD-pNA; Appearance Liquid Biovision 1000 assays 635.04
ASK
Publication
TO UP 1114-1000 Caspase 10 Substrate AEVD pNA Biovision 1000 assays 634.095
ASK
Publication
TO UP 1114-1000 Caspase 10 Substrate AEVD pNA1000 assays Biovision 1000 assays 579.285
ASK
Publication
TO UP 1114-200 Caspase-10 Substrate AEVD-pNA; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1114-200 Caspase 10 Substrate AEVD pNA Biovision 200 assays 311.85
ASK
Publication
TO UP 1114-200 Caspase 10 Substrate AEVD pNA200 assays Biovision 200 assays 287.28
ASK
Publication
TO UP 1115-100 Caspase-13 Inhibitor LEED-FMK Biovision 100 167
ASK
Publication
TO UP 1115-100 Caspase-13 Inhibitor LEED-FMK ; Appearance Liquid Biovision 100 171.99
ASK
Publication
TO UP 1115-100 Caspase 13 Inhibitor LEED FMK Biovision 100 µl (2 mM) 165.375
ASK
Publication
TO UP 1115-100 Caspase 13 Inhibitor LEED FMK 100 ul (2 mM) Biovision 100 ul (2 mM) 155.925
ASK
Publication
TO UP 1115-20C Caspase-13 Inhibitor LEED-FMK Biovision 20 167
ASK
Publication
TO UP 1115-20C Caspase-13 Inhibitor LEED-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1115-20C Caspase 13 Inhibitor LEED FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1115-20C Caspase 13 Inhibitor LEED FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1116-1000 Caspase-13 Substrate LEED-AFC; Appearance Liquid Biovision 1000 assays 614.25
ASK
Publication
TO UP 1116-1000 Caspase 13 Substrate LEED AFC Biovision 1000 assays 613.305
ASK
Publication
TO UP 1116-1000 Caspase 13 Substrate LEED AFC1000 assays Biovision 1000 assays 541.485
ASK
Publication
TO UP 1116-200 Caspase-13 Substrate LEED-AFC; Appearance Liquid Biovision 200 assays 311.85
ASK
Publication
TO UP 1116-200 Caspase 13 Substrate LEED AFC Biovision 200 assays 311.85
ASK
Publication
TO UP 1116-200 Caspase 13 Substrate LEED AFC200 assays Biovision 200 assays 276.885
ASK
Publication
TO UP 1117-1000 Caspase-12 Substrate ATAD-AFC; Appearance Liquid Biovision 1000 assays 1039.5
ASK
Publication
TO UP 1117-1000 Caspase 12 Substrate ATAD AFC Biovision 1000 assays 1039.5
ASK
Publication
TO UP 1117-1000 Caspase 12 Substrate ATAD AFC1000 assays Biovision 1000 assays 947.835
ASK
Publication
TO UP 1117-200 Caspase-12 Substrate ATAD-AFC; Appearance Liquid Biovision 200 assays 416.745
ASK
Publication
TO UP 1117-200 Caspase 12 Substrate ATAD AFC Biovision 200 assays 415.8
ASK
Publication
TO UP 1117-200 Caspase 12 Substrate ATAD AFC200 assays Biovision 200 assays 381.78
ASK
Publication
TO UP 1118-5 Active Granzyme B5 ug Biovision 5 ug 257.985
ASK
Publication
TO UP 1118-5 Granzyme B, human recombinant Biovision 5 ìg 357.21
ASK
Publication
TO UP 1120-20C Caspase Inhibitor Boc-D-FMK Biovision 20 167
ASK
Publication
TO UP 1120-20C Caspase Inhibitor Boc-D-FMK; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1120-20C Caspase Inhibitor Boc D FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1120-20C Caspase Inhibitor Boc D FMK20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1121-20C Biotin-IETD-FMK Biovision 20 338
ASK
Publication
TO UP 1121-20C Biotin-IETD-FMK; Appearance Liquid Biovision 20 353.43
ASK
Publication
TO UP 1121-20C Biotin IETD FMK Biovision 20 µl (10 mM) 357.21
ASK
Publication
TO UP 1121-20C Biotin IETD FMK20 ul (10 mM) Biovision 20 ul (10 mM) 325.08
ASK
Publication
TO UP 1122-100 FMK Negative Control Biovision 100 µl (2 mM) 154.035
ASK
Publication
TO UP 1122-100 FMK Negative Control 100 ul (2 mM) Biovision 100 ul (2 mM) 145.53
ASK
Publication
TO UP 1122-100 FMK Negative Control ; Appearance Liquid Biovision 100 161.595
ASK
Publication
TO UP 1122-20C FMK Negative Control Biovision 20 µl (10 mM) 154.035
ASK
Publication
TO UP 1122-20C FMK Negative Control 20 ul (10 mM) Biovision 20 ul (10 mM) 145.53
ASK
Publication
TO UP 1122-20C FMK Negative Control ; Appearance Liquid Biovision 20 161.595
ASK
Publication
TO UP 1123-20C Biotin-VAD-FMK Biovision 20 299
ASK
Publication
TO UP 1123-20C Biotin-VAD-FMK ; Appearance Liquid Biovision 20 311.85
ASK
Publication
TO UP 1123-20C Biotin VAD FMK Biovision 20 µl (10 mM) 314.685
ASK
Publication
TO UP 1123-20C Biotin VAD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 287.28
ASK
Publication
TO UP 1124-20C Biotin-DEVD-FMK Biovision 20 338
ASK
Publication
TO UP 1124-20C Biotin-DEVD-FMK; Appearance Liquid Biovision 20 353.43
ASK
Publication
TO UP 1124-20C Biotin DEVD FMK Biovision 20 µl (10 mM) 357.21
ASK
Publication
TO UP 1124-20C Biotin DEVD FMK20 ul (10 mM) Biovision 20 ul (10 mM) 325.08
ASK
Publication
TO UP 1125-20C Calpain Inhibitor Z-LLY-FMK Biovision 20 167
ASK
Publication
TO UP 1125-20C Calpain Inhibitor Z-LLY-FMK ; Appearance Liquid Biovision 20 171.99
ASK
Publication
TO UP 1125-20C Calpain Inhibitor Z LLY FMK Biovision 20 µl (10 mM) 165.375
ASK
Publication
TO UP 1125-20C Calpain Inhibitor Z LLY FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 155.925
ASK
Publication
TO UP 1126-20C Cathepsin B&L Inhibitor Z-Phe-Phe-FMK Biovision 20 211 Publication
TO UP 1126-20C Cathepsin B&L Inhibitor Z-Phe-Phe-FMK ; Appearance Liquid Biovision 20 219.24 Publication
TO UP 1126-20C Cathepsin B&L Inhibitor Z Phe Phe FMK Biovision 20 µl (10 mM) 207.9 Publication
TO UP 1126-20C Cathepsin B&L Inhibitor Z Phe Phe FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 193.725 Publication
TO UP 1127-20C EMAP-II Inhibitor Z-ASTD-FMK Biovision 20 240
ASK
Publication
TO UP 1127-20C EMAP-II Inhibitor Z-ASTD-FMK ; Appearance Liquid Biovision 20 249.48
ASK
Publication
TO UP 1127-20C EMAP II Inhibitor Z ASTD FMK Biovision 20 µl (10 mM) 250.425
ASK
Publication
TO UP 1127-20C EMAP II Inhibitor Z ASTD FMK 20 ul (10 mM) Biovision 20 ul (10 mM) 230.58
ASK
Publication
TO UP 1128-20C Granzyme B Inhibitor Z-AAD-CH2Cl Biovision 20 182
ASK
Publication
TO UP 1128-20C Granzyme B Inhibitor Z-AAD-CH2Cl; Appearance Liquid Biovision 20 187.11
ASK
Publication
TO UP 1128-20C Granzyme B Inhibitor Z AAD CH2Cl Biovision 20 µl (10 mM) 175.77
ASK
Publication
TO UP 1128-20C Granzyme B Inhibitor Z AAD CH2Cl20 ul (10 mM) Biovision 20 ul (10 mM) 164.43
ASK
Publication
TO UP 1130-5 JC 1 Biovision 5 mg 322
ASK
Publication
TO UP 1131-1 D2R [(L Asp)2 rhodamine 110] Biovision 1 mg 208
ASK
Publication
TO UP 1134-100 Active Human Calpain 1 Biovision 100 μg 385.224
ASK
Publication
TO UP 1134-100 Active Human Calpain I Biovision 100 ìg 389.34
ASK
Publication
TO UP 1134-100 Active Human Calpain I100 ug Biovision 100 ug 325.08
ASK
Publication
TO UP 1135-100 Active Cathepsin L100 ug Biovision 100 ug 325.08
ASK
Publication
TO UP 1135-100 Cathepsin L, human recombinant Biovision 100 ug 430.92
ASK
Publication
TO UP 1135-1000 Active Cathepsin L1 mg Biovision 1 mg 2544.89
ASK
Publication
TO UP 1135-1000 Cathepsin L, human recombinant Biovision 1 mg 2970.19
ASK
Publication
TO UP 1135-5 Active Cathepsin L5 ug Biovision 5 ug 137.025
ASK
Publication
TO UP 1135-5 Cathepsin L, human recombinant Biovision 5 ug 174.825
ASK
Publication
TO UP 1136-10 Histone Protein Biovision 10 mg 153.857
ASK
Publication
TO UP 1136-10 Histone Protein10 mg Biovision 10 mg 139.86
ASK
Publication
TO UP 1137-100 Active Rec. HAT (P CAF)100 ug Biovision 100 ug 295.785
ASK
Publication
TO UP 1137-100 HAT (P/CAF), human recombinant Biovision 100 μg 322.245
ASK
Publication
TO UP 1137-100 HAT (P CAF), human recombinant Biovision 100 ìg 325.08
ASK
Publication
TO UP 1139-1000 SCLP 210 Protein1 mg[DISCONTINUED] Biovision 1 mg 1225.61
ASK
Publication
TO UP 1140-1 Z-VAD-FMK; Appearance Lyophilized solid Biovision 1 mg 260.82 Publication
TO UP 1140-1 Z VAD FMK Biovision 1 mg 259.875 Publication
TO UP 1140-1 Z VAD FMK1 mg Biovision 1 mg 230.58 Publication
TO UP 1140-5 Z-VAD-FMK; Appearance Lyophilized solid Biovision 5 mg 738.99
ASK
Publication
TO UP 1140-5 Z VAD FMK Biovision 5 mg 738.045
ASK
Publication
TO UP 1140-5 Z VAD FMK5 mg Biovision 5 mg 659.61
ASK
Publication
TO UP 1141-1 Z-YVAD-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1141-1 Z YVAD FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1141-1 Z YVAD FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1141-5 Z-YVAD-FMK; Appearance Lyophilized solid Biovision 5 mg 738.99
ASK
Publication
TO UP 1141-5 Z YVAD FMK Biovision 5 mg 738.045
ASK
Publication
TO UP 1141-5 Z YVAD FMK5 mg Biovision 5 mg 659.61
ASK
Publication
TO UP 1142-1 Z-VDVAD-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1142-1 Z VDVAD FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1142-1 Z VDVAD FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1142-5 Z-VDVAD-FMK; Appearance Lyophilized solid Biovision 5 mg 770.175
ASK
Publication
TO UP 1142-5 Z VDVAD FMK Biovision 5 mg 769.23
ASK
Publication
TO UP 1142-5 Z VDVAD FMK5 mg Biovision 5 mg 702.135
ASK
Publication
TO UP 1143-1 Z-DEVD-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1143-1 Z DEVD FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1143-1 Z DEVD FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1143-5 Z-DEVD-FMK; Appearance Lyophilized solid Biovision 5 mg 770.175
ASK
Publication
TO UP 1143-5 Z DEVD FMK Biovision 5 mg 769.23
ASK
Publication
TO UP 1143-5 Z DEVD FMK5 mg Biovision 5 mg 702.135
ASK
Publication
TO UP 1144-1 Z-LEVD-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1144-1 Z LEVD FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1144-1 Z LEVD FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1144-5 Z-LEVD-FMK; Appearance Lyophilized solid Biovision 5 mg 770.175
ASK
Publication
TO UP 1144-5 Z LEVD FMK Biovision 5 mg 769.23
ASK
Publication
TO UP 1144-5 Z LEVD FMK5 mg Biovision 5 mg 702.135
ASK
Publication
TO UP 1146-1 Z-VEID-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1146-1 Z VEID FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1146-1 Z VEID FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1146-5 Z-VEID-FMK; Appearance Lyophilized solid Biovision 5 mg 770.175
ASK
Publication
TO UP 1146-5 Z VEID FMK Biovision 5 mg 769.23
ASK
Publication
TO UP 1146-5 Z VEID FMK5 mg Biovision 5 mg 702.135
ASK
Publication
TO UP 1148-1 Z-IETD-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1148-1 Z IETD FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1148-1 Z IETD FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1148-5 Z-IETD-FMK; Appearance Lyophilized solid Biovision 5 mg 722.925
ASK
Publication
TO UP 1148-5 Z IETD FMK Biovision 5 mg 722.925
ASK
Publication
TO UP 1148-5 Z IETD FMK5 mg Biovision 5 mg 659.61
ASK
Publication
TO UP 1149-1 Z-LEHD-FMK; Appearance Lyophilized solid Biovision 1 mg 291.06
ASK
Publication
TO UP 1149-1 Z LEHD FMK Biovision 1 mg 291.06
ASK
Publication
TO UP 1149-1 Z LEHD FMK1 mg Biovision 1 mg 268.38
ASK
Publication
TO UP 1149-5 Z-LEHD-FMK; Appearance Lyophilized solid Biovision 5 mg 722.925
ASK
Publication
TO UP 1149-5 Z LEHD FMK Biovision 5 mg 722.925
ASK
Publication
TO UP 1149-5 Z LEHD FMK5 mg Biovision 5 mg 659.61
ASK
Publication
TO UP 1152-1 Z-ATAD-FMK; Appearance Lyophilized solid Biovision 1 mg 323.19
ASK
Publication
TO UP 1152-1 Z ATAD FMK Biovision 1 mg 322.245
ASK
Publication
TO UP 1152-1 Z ATAD FMK1 mg Biovision 1 mg 295.785
ASK
Publication
TO UP 1152-5 Z-ATAD-FMK; Appearance Lyophilized solid Biovision 5 mg 874.125
ASK
Publication
TO UP 1152-5 Z ATAD FMK Biovision 5 mg 873.18
ASK
Publication
TO UP 1152-5 Z ATAD FMK5 mg Biovision 5 mg 796.635
ASK
Publication
TO UP 1160-1 Boc-D-FMK; Appearance Lyophilized solid Biovision 1 mg 177.66
ASK
Publication
TO UP 1160-1 Boc D FMK Biovision 1 mg 176.715
ASK
Publication
TO UP 1160-1 Boc D FMK1 mg Biovision 1 mg 164.43
ASK
Publication
TO UP 1160-5 Boc-D-FMK; Appearance Lyophilized solid Biovision 5 mg 458.325
ASK
Publication
TO UP 1160-5 Boc D FMK Biovision 5 mg 457.38
ASK
Publication
TO UP 1160-5 Boc D FMK5 mg Biovision 5 mg 419.58
ASK
Publication
TO UP 1170-1 Q-VD-OPh; Appearance Lyophilized solid Biovision 1 mg 249.48 Publication
TO UP 1170-1 Q VD OPh Biovision 1 mg 248 Publication
TO UP 1170-1 Q VD OPH1 mg Biovision 1 mg 230.58 Publication
TO UP 1170-3 Q-VD-OPh Biovision 3 mg 474 Publication
TO UP 1170-3 Q-VD-OPh; Appearance Lyophilized solid Biovision 3 mg 498.96 Publication
TO UP 1170-5 Q-VD-OPh; Appearance Lyophilized solid Biovision 5 mg 770.175
ASK
Publication
TO UP 1170-5 Q VD OPh Biovision 5 mg 769
ASK
Publication
TO UP 1170-5 Q VD OPH5 mg Biovision 5 mg 672.84
ASK
Publication
TO UP 1171-1 QVD-OPh Negative Control; Appearance Lyophilized solid Biovision 1 mg 219.24
ASK
Publication
TO UP 1171-1 QVD OPh Negative Control Biovision 1 mg 218.295
ASK
Publication
TO UP 1171-1 QVD OPH Negative Control1 mg Biovision 1 mg 202.23
ASK
Publication
TO UP 1171-3 QVD-OPh Negative Control Biovision 3 mg 406 Publication
TO UP 1171-3 QVD-OPh Negative Control; Appearance Lyophilized solid Biovision 3 mg 427.14 Publication
TO UP 1171-5 QVD-OPh Negative Control; Appearance Lyophilized solid Biovision 5 mg 635.04
ASK
Publication
TO UP 1171-5 QVD OPh Negative Control Biovision 5 mg 634.095
ASK
Publication
TO UP 1171-5 QVD OPH Negative Control5 mg Biovision 5 mg 579.285
ASK
Publication
TO UP 1173-1 EZSolution™ Q VD OPh Biovision 1 mg 249 Publication
TO UP 1174-1 EZSolution™ Q VD OPh, Negative Control Biovision 1 mg 218 Publication
TO UP 1175-1 Caspase-3 Inhibitor Q-DEVD-OPh Biovision 1 mg 240 Publication
TO UP 1175-1 Caspase-3 Inhibitor Q-DEVD-OPh; Appearance Off-white solid Biovision 1 mg 249.48 Publication
TO UP 1175-3 Caspase-3 Inhibitor Q-DEVD-OPh Biovision 3 mg 474 Publication
TO UP 1175-3 Caspase-3 Inhibitor Q-DEVD-OPh; Appearance Off-white solid Biovision 3 mg 498.96 Publication
TO UP 1175-5 Caspase-3 Inhibitor Q-DEVD-OPh Biovision 5 mg 728 Publication
TO UP 1175-5 Caspase-3 Inhibitor Q-DEVD-OPh; Appearance Off-white solid Biovision 5 mg 770.175 Publication
TO UP 1181-100 Active Mouse Caspase 1100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1181-100 Caspase 1, mouse recombinant Biovision 100 units 354.501
ASK
Publication
TO UP 1181-25 Active Mouse Caspase 125 units Biovision 25 units 202.23
ASK
Publication
TO UP 1181-25 Caspase 1, mouse recombinant Biovision 25 units 231.651
ASK
Publication
TO UP 1183-100 Active Mouse Caspase 3100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1183-100 Caspase 3, mouse recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1183-25 Active Mouse Caspase 325 units Biovision 25 units 164.43
ASK
Publication
TO UP 1183-25 Caspase 3, mouse recombinant Biovision 25 units 200.949
ASK
Publication
TO UP 1183P-5 Caspase-3 Proform, mouse recombinant Biovision 5 μg 385.224
ASK
Publication
TO UP 1183P-5 Caspase-3 Proform, mouse recombinant CASP3 Mouse Biovision 5 μg 342
ASK
Publication
TO UP 1183P-5 Caspase 3 Proform, mouse recombinant Biovision 5 ug 430.92
ASK
Publication
TO UP 1183P-5 Mouse Procaspase 35 ug Biovision 5 ug 325.08
ASK
Publication
TO UP 1188-100 Active Mouse Caspase 8100 units Biovision 100 units 295.785
ASK
Publication
TO UP 1188-100 Caspase 8, mouse recombinant Biovision 100 units 344.274
ASK
Publication
TO UP 1188-25 Active Mouse Caspase 825 units Biovision 25 units 164.43
ASK
Publication
TO UP 1188-25 Caspase 8, mouse recombinant Biovision 25 units 200.949
ASK
Publication
TO UP 1201-1 DTT Biovision 1 ml (1 M) 114
ASK
Publication
TO UP 1202-10G TCEP.HCl Biovision 10 g 332 Publication
TO UP 1202-1ML TCEP.HCl Biovision 1 ml (1 M) 137 Publication
TO UP 1203-10 Ethidium Bromide Biovision 10 ml 108
ASK
Publication
TO UP 1209-10 Trypan Blue (0.4%) Biovision 10 ml 108
ASK
Publication
TO UP 1211-20 SuperMOUNT™ Mounting Medium Biovision 20 ml 186
ASK
Publication
TO UP 1212-100 ABTS™ Biovision 100 ml 138 Publication
TO UP 1215-100 TMB, Ultrasensitive Biovision 100 ml 143 Publication
TO UP 1216-100 TMB, High Kinetics Biovision 100 ml 162 Publication
TO UP 1241-1 Oxidized Glutathione (GSSG)1 g Biovision 1 g 121
ASK
Publication
TO UP 1242-1 Reduced Glutathione (GSH) Biovision 1 g 133
ASK
Publication
TO UP 1243-1 Active GST Protein Biovision 1 mg 148
ASK
Publication
TO UP 1266-100 CaspGLOW Wash Buffer100 ml[DISCONTINUED] Biovision 100 ml 126.932
ASK
Publication
TO UP 1267-1 Rabbit Serum Biovision 1 ml 147
ASK
Publication
TO UP 1268-100 Rabbit IgG, 100 μg Biovision 100 μg 143
ASK
Publication
TO UP 1283-100 Caspase 3, rat recombinant Biovision 100 units 306
ASK
Publication
TO UP 1283-25 Caspase 3, rat recombinant Biovision 25 units 200
ASK
Publication
TO UP 1501-10 A2318710 mg Biovision 10 mg 149
ASK
Publication
TO UP 1505-100 Arachidonic Acid Biovision 100 mg 152
ASK
Publication
TO UP 1506-1000 Aurintricarboxylic acid1 g Biovision 1 g 118
ASK
Publication
TO UP 1519-1000 Colchicine1 g Biovision 1 g 118
ASK
Publication
TO UP 1522-100 Cyclosporine A Biovision 100 mg 133
ASK
Publication
TO UP 1522-1G Cyclosporine A Biovision 1 g 240 Publication
TO UP 1524-10 Daunorubicin.HCl Biovision 10 mg 123
ASK
Publication
TO UP 1524-50 Daunorubicin.HCl Biovision 50 mg 269 Publication
TO UP 1524-500 Daunorubicin.HCl Biovision 500 mg 1464 Publication
TO UP 1527-5 Doxorubicin.HCl Biovision 5 mg 123
ASK
Publication
TO UP 1531-5 Forskolin Biovision 5 mg 123
ASK
Publication
TO UP 1533-10 Genistein10 mg Biovision 10 mg 118
ASK
Publication
TO UP 1533-100 Genistein100 mg Biovision 100 mg 231
ASK
Publication
TO UP 1535-10 Genistin10 mg Biovision 10 mg 140
ASK
Publication
TO UP 1543-025 Okadaic acid Biovision 25 143
ASK
Publication
TO UP 1544-5 Phorbol 12 myristate 13 acetate (PMA)5 mg Biovision 5 mg 156 Publication
TO UP 1545-100G CHAPS, High Purity Biovision 100 g 513 Publication
TO UP 1545-10G CHAPS, High Purity Biovision 10 g 113 Publication
TO UP 1545-1Kg CHAPS, High Purity Biovision 1 Kg 2780 Publication
TO UP 1545-500G CHAPS, High Purity Biovision 500 g 1951 Publication
TO UP 1545-50G CHAPS, High Purity Biovision 50 g 304 Publication
TO UP 1547-1 FAS Inhibitor, C75 Biovision 1 mg 152 Publication
TO UP 1548-5 PMSF Biovision 5 g 143
ASK
Publication
TO UP 1549-10 Anisomycin10 mg Biovision 10 mg 137
ASK
Publication
TO UP 1550-100 Cisplatin100 mg Biovision 100 mg 121 Publication
TO UP 1550-1000 Cisplatin Biovision 1 g 338 Publication
TO UP 1551-1000 Tamoxifen citrate1 g Biovision 1 g 140
ASK
Publication
TO UP 1552-100 Betulinic acid Biovision 100 mg 328 Publication
TO UP 1552-25 Betulinic acid Biovision 25 mg 127
ASK
Publication
TO UP 1553-100 Carboplatin100 mg Biovision 100 mg 137
ASK
Publication
TO UP 1554-10 Pifithrin-ɑ Biovision 10 mg 152
ASK
Publication
TO UP 1555-1000 GST Inhibitor 1 (Cibacron Blue 3G A)1 g[DISCONTINUED] Biovision 1 g 159.299
ASK
Publication
TO UP 1555R-1000 GST Inhibitor 1 (Cibacron Blue 3G A, Sodium Salt) Biovision 1 g 170 Publication
TO UP 1556-1000 GST Inhibitor 2 (Ethacrynic acid))1 g Biovision 1 g 121
ASK
Publication
TO UP 1557-1000 G418 Sulfate (siRNA Vector Approved)1 g[DISCONTINUED] Biovision 1 g 140.446
ASK
Publication
TO UP 1557-1000 G418 Sulfate (siRNA Vector Approved)[DISCONTINUED] Biovision 1 g 112.124
ASK
Publication
TO UP 1557-1G G418 Sulfate Biovision 1 g 123 Publication
TO UP 1557-25G G418 Sulfate Biovision 25 g 1044 Publication
TO UP 1557-5G G418 Sulfate Biovision 5 g 284 Publication
TO UP 1558-1 Thapsigargin1 mg Biovision 1 mg 137
ASK
Publication
TO UP 1559-100 Rosiglitazone Biovision 100 mg 328
ASK
Publication
TO UP 1559-5 Rosiglitazone Biovision 5 mg 94
ASK
Publication
TO UP 1559-50 Rosiglitazone Biovision 50 mg 230 Publication
TO UP 1560-5 Brefeldin A Biovision 5 mg 133
ASK
Publication
TO UP 1560-50 Brefeldin A Biovision 50 mg 396 Publication
TO UP 1561-50 Mifepristone Biovision 50 mg 244
ASK
Publication
TO UP 1562-025 Calyculin A Biovision 25 ug 208
ASK
Publication
TO UP 1563-1 FK 506 Biovision 1 mg 108
ASK
Publication
TO UP 1563-10 FK 506 Biovision 10 mg 249
ASK
Publication
TO UP 1564-1 Geldanamycin Biovision 1 mg 127
ASK
Publication
TO UP 1564-5 Geldanamycin Biovision 5 mg 338 Publication
TO UP 1565-5 Ionomycin (free acid) Biovision 5 mg 406
ASK
Publication
TO UP 1566-5 Ionomycin (Calcium salt) Biovision 5 mg 386
ASK
Publication
TO UP 1567-25 Paclitaxel25 mg Biovision 25 mg 231
ASK
Publication
TO UP 1568-5 Rapamycin Biovision 5 mg 240
ASK
Publication
TO UP 1568-50 Rapamycin Biovision 50 mg 991
ASK
Publication
TO UP 1570-5 Tyrphostin AG 4905 mg Biovision 5 mg 137
ASK
Publication
TO UP 1571-5 Tyrphostin AG 12955 mg Biovision 5 mg 231
ASK
Publication
TO UP 1572-10-5 OxiRedTM Probe 10x5 mg Biovision 10x5 mg 796.635
ASK
Publication
TO UP 1572-10-5 OxiRed™ Probe Biovision 10x5 mg 891.135
ASK
Publication
TO UP 1572-10-5 OxiRed™ Probe ; Appearance White to pink solid Biovision 10x5 mg 874.125
ASK
Publication
TO UP 1572-20-5 OxiRedTM Probe 20x5 mg Biovision 20x5 mg 1426.95 Publication
TO UP 1572-20-5 OxiRed™ Probe Biovision 20x5 mg 1606.5 Publication
TO UP 1572-20-5 OxiRed™ Probe ; Appearance White to pink solid Biovision 20x5 mg 1570.59 Publication
TO UP 1572-5 OxiRedTM Probe 5 mg Biovision 5 mg 137
ASK
Publication
TO UP 1573-2 Ascomycin Biovision 2 mg 240
ASK
Publication
TO UP 1574-100 Celecoxib Biovision 100 mg 152
ASK
Publication
TO UP 1574-100 Celecoxib100 mg Biovision 100 mg 230.58
ASK
Publication
TO UP 1574-100 Celecoxib; Appearance Off-white solid Biovision 100 mg 156.87
ASK
Publication
TO UP 1574-1000 Celecoxib Biovision 1 g 367 Publication
TO UP 1574-1000 Celecoxib; Appearance Off-white solid Biovision 1 g 385.56 Publication
TO UP 1575-5 Bexarotene Biovision 5 mg 143
ASK
Publication
TO UP 1575-5 Bexarotene5 mg Biovision 5 mg 230
ASK
Publication
TO UP 1575-5 Bexarotene; Appearance Off-white solid Biovision 5 mg 145.53
ASK
Publication
TO UP 1575-50 Bexarotene Biovision 50 mg 338 Publication
TO UP 1575-50 Bexarotene50 mg Biovision 50 mg 702.135 Publication
TO UP 1575-50 Bexarotene; Appearance Off-white solid Biovision 50 mg 353.43 Publication
TO UP 1576-5 Nedaolatin5 mg Biovision 5 mg 231
ASK
Publication
TO UP 1577-25 Oxaliplatin25 mg Biovision 25 mg 231
ASK
Publication
TO UP 1578-5 Cyclopamine5 mg Biovision 5 mg 231
ASK
Publication
TO UP 1579-5 Cerulenin Biovision 5 mg 157 Publication
TO UP 1579-5 Cerulenin5 mg Biovision 5 mg 139.86 Publication
TO UP 1579-5 Cerulenin; Appearance White to off-white solid Biovision 5 mg 161.595 Publication
TO UP 1579-50 Cerulenin Biovision 50 mg 757 Publication
TO UP 1579-50 Cerulenin50 mg Biovision 50 mg 702 Publication
TO UP 1579-50 Cerulenin; Appearance White to off-white solid Biovision 50 mg 801.36 Publication
TO UP 1580-100 GSNO Biovision 100 mg 338 Publication
TO UP 1580-100 GSNO ; Appearance Pink solid Biovision 100 mg 353.43 Publication
TO UP 1580-25 GSNO Biovision 25 mg 147 Publication
TO UP 1580-25 GSNO ; Appearance Pink solid Biovision 25 mg 150.255 Publication
TO UP 1581-25 Axitinib (AG 013736) Biovision 25 mg 353 Publication
TO UP 1581-5 Axitinib (AG 013736) Biovision 5 mg 177 Publication
TO UP 1582-25 Saracatinib (AZD0530) Biovision 25 mg 825 Publication
TO UP 1582-5 Saracatinib (AZD0530) Biovision 5 mg 308 Publication
TO UP 1583-25 ADZ1152 HQPA Biovision 25 mg 655.83 Publication
TO UP 1583-25 Aurora Kinase B Inhibitor (AZD1152-HQPA) Biovision 25 mg 611 Publication
TO UP 1583-25 Aurora Kinase B Inhibitor (AZD1152-HQPA); Appearance Crystalline solid Biovision 25 mg 644.49 Publication
TO UP 1583-5 ADZ1152 HQPA Biovision 5 mg 218.295 Publication
TO UP 1583-5 Aurora Kinase B Inhibitor (AZD1152-HQPA) Biovision 5 mg 240 Publication
TO UP 1583-5 Aurora Kinase B Inhibitor (AZD1152-HQPA); Appearance Crystalline solid Biovision 5 mg 249.48 Publication
TO UP 1584-25 Bosutinib (SKI-606) SKI-606 Biovision 25 mg 225 Publication
TO UP 1584-5 Bosutinib (SKI 606) Biovision 5 mg 146 Publication
TO UP 1585-1 PD184352 Biovision 1 mg 116 Publication
TO UP 1585-1 PD184352; Appearance Crystalline solid Biovision 1 mg 118.125 Publication
TO UP 1585-25 PD184352 Biovision 25 mg 796 Publication
TO UP 1585-25 PD184352; Appearance Crystalline solid Biovision 25 mg 842.94 Publication
TO UP 1585-5 PD184352 Biovision 5 mg 308 Publication
TO UP 1585-5 PD184352; Appearance Crystalline solid Biovision 5 mg 323.19 Publication
TO UP 1586-100 Dasatinib (BMS-354825, Sprycel); Appearance White to off-white solid Biovision 100 mg 281.61 Publication
TO UP 1586-100 Dasatinib (BMS 354825, Sprycel) Biovision 100 mg 280 Publication
TO UP 1586-25 Dasatinib (BMS-354825, Sprycel); Appearance White to off-white solid Biovision 25 mg 156.87 Publication
TO UP 1586-25 Dasatinib (BMS 354825, Sprycel) Biovision 25 mg 155 Publication
TO UP 1587-25 Deforolimus Biovision 25 mg 923 Publication
TO UP 1587-25 Deforolimus; Appearance White to off-white solid Biovision 25 mg 977.13 Publication
TO UP 1587-5 Deforolimus Biovision 5 mg 338 Publication
TO UP 1587-5 Deforolimus; Appearance White to off-white solid Biovision 5 mg 353.43 Publication
TO UP 1588-100 Erlotinib, Hydrochloride Salt Biovision 100 mg 143 Publication
TO UP 1588-100 Erlotinib, Hydrochloride Salt; Appearance White to off-white solid Biovision 100 mg 145.53 Publication
TO UP 1588-1000 Erlotinib, Hydrochloride Salt Biovision 1 g 338 Publication
TO UP 1588-1000 Erlotinib, Hydrochloride Salt; Appearance White to off-white solid Biovision 1 g 353.43 Publication
TO UP 1589-25 Gefitinib Biovision 25 mg 240 Publication
TO UP 1589-25 Gefitinib; Appearance White to off-white solid Biovision 25 mg 249.48 Publication
TO UP 1589-5 Gefitinib Biovision 5 mg 143 Publication
TO UP 1589-5 Gefitinib; Appearance White to off-white solid Biovision 5 mg 145.53 Publication
TO UP 1590-1 MS 275 (Entinostat, SNDX 275) Biovision 1 mg 322 Publication
TO UP 1590-5 MS-275 (Entinostat, SNDX-275); Appearance Crystalline solid Biovision 5 mg 874.125 Publication
TO UP 1590-5 MS 275 (Entinostat, SNDX 275) Biovision 5 mg 873 Publication
TO UP 1591-1 NVP-AUY922; Appearance White to off-white solid Biovision 1 mg 353.43 Publication
TO UP 1591-1 NVP AUY922 Biovision 1 mg 353 Publication
TO UP 1591-5 NVP-AUY922; Appearance White to off-white solid Biovision 5 mg 977.13 Publication
TO UP 1591-5 NVP AUY922 Biovision 5 mg 977 Publication
TO UP 1592-25 Perifosine (KRX 0401) Biovision 25 mg 665 Publication
TO UP 1592-5 Perifosine (KRX 0401) Biovision 5 mg 249 Publication
TO UP 1593-25 Pimecrolimus Biovision 25 mg 308 Publication
TO UP 1593-5 Pimecrolimus Biovision 5 mg 172 Publication
TO UP 1594-100 BAY 43-9006 Biovision 100 mg 367 Publication
TO UP 1594-100 Sorafenib Biovision 100 mg 399.735 Publication
TO UP 1594-100 Sorafenib; Appearance Off-white solid Biovision 100 mg 385.56 Publication
TO UP 1594-25 BAY 43-9006 Biovision 25 mg 152 Publication
TO UP 1594-25 Sorafenib Biovision 25 mg 165.375 Publication
TO UP 1594-25 Sorafenib; Appearance Off-white solid Biovision 25 mg 156.87 Publication
TO UP 1595-100 Tozasertib (VX 680, MK 0457, VX6) Biovision 100 mg 353 Publication
TO UP 1595-25 Tozasertib (VX 680, MK 0457, VX6) Biovision 25 mg 146 Publication
TO UP 1596-1 Y-27632, dihydrochloride Biovision 1 mg 143 Publication
TO UP 1596-1 Y-27632, dihydrochloride; Appearance White soild Biovision 1 mg 145.53 Publication
TO UP 1596-1 Y 27632 Biovision 1 mg 144.585 Publication
TO UP 1596-5 Y-27632, dihydrochloride Biovision 5 mg 386 Publication
TO UP 1596-5 Y-27632, dihydrochloride; Appearance White soild Biovision 5 mg 406.35 Publication
TO UP 1596-5 Y 27632 Biovision 5 mg 345.87 Publication
TO UP 1596-50 Y-27632, dihydrochloride Biovision 50 mg 2093 Publication
TO UP 1596-50 Y-27632, dihydrochloride; Appearance White soild Biovision 50 mg 2224.53 Publication
TO UP 1596-50 Y 27632 Biovision 50 mg 1746.36 Publication
TO UP 1598-1 VX-702; Appearance White soild Biovision 1 mg 353.43 Publication
TO UP 1598-1 VX 702 Biovision 1 mg 353 Publication
TO UP 1598-5 VX-702; Appearance White soild Biovision 5 mg 977.13 Publication
TO UP 1598-5 VX 702 Biovision 5 mg 977 Publication
TO UP 1599-1 Vicriviroc Malate Biovision 1 mg 338 Publication
TO UP 1599-1 Vicriviroc Malate; Appearance Crystalline solid Biovision 1 mg 318 Publication
TO UP 1599-5 Vicriviroc Malate Biovision 5 mg 923 Publication
TO UP 1599-5 Vicriviroc Malate; Appearance Crystalline solid Biovision 5 mg 977.13 Publication
TO UP 1600-25 Temsirolimus (CCI 779, Torisel) Biovision 25 mg 873 Publication
TO UP 1600-5 Temsirolimus (CCI 779, Torisel) Biovision 5 mg 322 Publication
TO UP 1601-1 Apicidin Biovision 1 mg 152
ASK
Publication
TO UP 1604-1 SAHA Biovision 1 mg 182 Publication
TO UP 1606-1 Trichostatin A Biovision 1 mg 182
ASK
Publication
TO UP 1607-1 M344 Biovision 1 mg 162
ASK
Publication
TO UP 1608-100 Sodium 4-phenylbutyrate; Appearance White to yellowish solid Biovision 100 mg 124.74
ASK
Publication
TO UP 1608-100 Sodium 4 phenylbutyrate Biovision 100 mg 124
ASK
Publication
TO UP 1608-100 Sodium 4 phenylbutyrate100 mg Biovision 100 mg 118.125
ASK
Publication
TO UP 1608-1000 Sodium 4-phenylbutyrate Biovision 1 g 338
ASK
Publication
TO UP 1608-1000 Sodium 4-phenylbutyrate; Appearance White to yellowish solid Biovision 1 g 353.43
ASK
Publication
TO UP 1608-1000 Sodium 4 phenylbutyrate Biovision 1 gram 357.21
ASK
Publication
TO UP 1608-1000 Sodium 4 phenylbutyrate1 gram Biovision 1 gram 325.08
ASK
Publication
TO UP 1609-1000 Sodium butyrate Biovision 1 g 172
ASK
Publication
TO UP 1610-5 Splitomicin5 mg Biovision 5 mg 145
ASK
Publication
TO UP 1611-100 Sunitinib Malate (Sutent) Biovision 100 mg 172 Publication
TO UP 1611-100 Sunitinib Malate (Sutent); Appearance Yellow-orange powder Biovision 100 mg 177.66 Publication
TO UP 1611-1000 Sunitinib Malate (Sutent) Biovision 1 g 435 Publication
TO UP 1611-1000 Sunitinib Malate (Sutent); Appearance Yellow-orange powder Biovision 1 g 458.325 Publication
TO UP 1611-25 Sunitinib Malate (Sutent) Biovision 25 mg 104 Publication
TO UP 1611-25 Sunitinib Malate (Sutent); Appearance Yellow-orange powder Biovision 25 mg 103.95 Publication
TO UP 1612-1 Panobinostat (LBH589) Biovision 1 mg 152 Publication
TO UP 1612-1 Panobinostat (LBH589); Appearance Crystalline solid Biovision 1 mg 156.87 Publication
TO UP 1612-25 Panobinostat (LBH589) Biovision 25 mg 1020 Publication
TO UP 1612-25 Panobinostat (LBH589); Appearance Crystalline solid Biovision 25 mg 1081.08 Publication
TO UP 1612-5 Panobinostat (LBH589) Biovision 5 mg 367 Publication
TO UP 1612-5 Panobinostat (LBH589); Appearance Crystalline solid Biovision 5 mg 385.56 Publication
TO UP 1613-1 Cediranib (AZD2171) Biovision 1 mg 143 Publication
TO UP 1613-1 Cediranib (AZD2171); Appearance Crystalline solid Biovision 1 mg 145.53 Publication
TO UP 1613-5 Cediranib (AZD2171) Biovision 5 mg 420 Publication
TO UP 1613-5 Cediranib (AZD2171); Appearance Crystalline solid Biovision 5 mg 442.26 Publication
TO UP 1614-1 BMS-599626; Appearance Crystalline solid Biovision 1 mg 353.43